To assess the predictors of postoperative medical and surgical complications in patients with limited life expectancy treated with partial nephrectomy (PN) for renal tumors in a large multicenter prospective observational study.
INTRODUCTION AND OBJECTIVES:
To assess the predictors of postoperative medical and surgical complications in patients with limited life expectancy treated with partial nephrectomy (PN) for renal tumors in a large multicenter prospective observational study.
METHODS: We prospectively gathered clinical data of 2,584 patients treated with PN at 26 urological Italian Centers from January 2013 to December 2016 (RECORd 2 project). Limited life expectancy was defined as an estimated 10-year survival (assessed using the ageadjusted Charlson comorbidity index (CCI)) <50%. Medical and surgical postoperative complications occurring within 30 days of surgery were assessed and graded using the modified ClavienDindo scale.
RESULTS: Overall, the median estimated 10-year survival was 72.1% (IQR 26.4%-90.1%): 874 (33.8%) patients had a limited life expectancy. Of these, the median age-adjusted CCI and American Society of Anesthesiologists (ASA) physical status (PS) score were 6 (5-7) and 2 (2-3). Patients had a median baseline estimated glomerular filtration rate (eGFR) of 74.9 (62.3-88.4). The cT1b and cT2 renal tumors were reported in 21.4% and 3.0% of cases. The median PADUA score was 7 (IQR 7-9).
Patients were treated with open, laparoscopic and robotic PN in 326 (37.3%), 226 (25.9%) and 322 (36.8%). Patients were treated in high-volume centres (>50 PN/year) in 584 (66.8%) of cases.
Medical complications were reported in 65 (7.4%) cases: 22 (2.5%) were Clavien 1, 26 (3%) Clavien 2, 2 (0.2%) Clavien 3a, 2 (0.2%) Clavien 5. Surgical complications were reported in 148 (16.9%) cases: 32 (3.7%) were Clavien 1, 86 (9.8%) Clavien 2, 10 (1.1%) Clavien 3a, 15 (1.7%) Clavien 3b, 4 (0.5%) Clavien 4.
At multivariable analyses, ASA PS score (OR 2. (PN vs RN) . Hilar tumors were defined as those at medial position, abutting the renal artery and/or vein or its segmental branches, identified on pre-operative axial imaging and subsequently confirmed intra-operatively. The Kaplan-Meier method was used to estimate recurrence-free (RFS), cancer-specific (CSS) and overall survival (OS). The log-rank test was used to test for differences between groups RESULTS: Among the 2,022 included patients, 444 had hilar tumors (323 scheduled for PN, 121 RN) and 1578 (all scheduled for PN) had non-hilar tumors. Median follow-up for survivors was 3.4 (IQR 1.4, 6.0) years following surgery. A higher proportion of patients with hilar tumors scheduled to undergo PN were converted to RN compared to non-hilar tumors (5.6 vs 0.7%, difference 4.9%, 95% CI 2.3% 7%, p <0.0001). Positive margin rates following PN for hilar and non-hilar tumors were similar (5.6 vs 5.1%; p [ 0.7). Mean eGFR at 6 months post-operatively was lower in hilar tumors compared to non-hilar (67 vs 74 ml/min/1.73m2; p < 0.0001). Hilar tumors had more grade 2 or higher complications (within 30 days of surgery) compared to nonhilar tumors (13% vs 8.5%; p [ 0.017). Among all patients who were scheduled to undergo PN, 28 patients had a recurrence. Compared to non-hilar tumors, hilar tumors had no significant differences in RFS (p [ 0. 
